Holen Sie sich die Stockscreener-App
7.96
2.31%
0.18
Vorhandelsmarkt:
8.03
0.07
+0.88%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CAPR?
Forum
Prognose
Aktiensplit
Capricor Therapeutics Inc Aktie (CAPR) Neueste Nachrichten
CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
Best data tools to analyze Capricor Therapeutics Inc. stockJuly 2025 Drop Watch & Daily Stock Trend Reports - Newser
What makes Capricor Therapeutics Inc. stock price move sharplyGap Up & Low Risk High Win Rate Stock Picks - Newser
CAPR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Capricor - Bluefield Daily Telegraph
Momentum divergence signals in Capricor Therapeutics Inc. chartQuarterly Profit Review & AI Powered Market Entry Ideas - Newser
Live market analysis of Capricor Therapeutics Inc.Rate Hike & Technical Confirmation Trade Alerts - Newser
Applying big data sentiment scoring on Capricor Therapeutics Inc.Share Buyback & AI Powered Market Trend Analysis - Newser
Bragar Eagel & Squire, P.C. Urges Investors in XPLR - GlobeNewswire
Bragar Eagel & Squire, P.C. Urges Investors in XPLR Infrastructure, Centene, Biohaven, or Capricor to Inquire About Their Rights in Class Action Lawsuits - GlobeNewswire Inc.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc.CAPR - PR Newswire
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors to Secure ... - Eagle-Tribune
Published on: 2025-08-16 02:13:07 - Newser
Published on: 2025-08-15 23:36:43 - beatles.ru
Capricor Therapeutics, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationCAPR - WV News
Faruqi & Faruqi Reminds Capricor Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 15, 2025CAPR - The Malaysian Reserve
Custom watchlist performance reports with Capricor Therapeutics Inc.New Guidance & Smart Money Movement Alerts - Newser
CAPR FY2025 EPS Estimate Lowered by Cantor Fitzgerald - Defense World
HC Wainwright Issues Pessimistic Estimate for CAPR Earnings - Defense World
Roth Capital Has Bearish Estimate for CAPR Q3 Earnings - Defense World
Class Action Lawsuit Filed Against Capricor Therapeutics, Inc. (CAPR)Recover LossesContact Levi & Korsinsky Before September 15, 2025 - ACCESS Newswire
Transcript : Capricor Therapeutics, Inc., Q2 2025 Earnings Call, Aug 11, 2025 - MarketScreener
Levi & Korsinsky Notifies Shareholders of Capricor Therapeutics, Inc.(CAPR) of a Class ... - Bluefield Daily Telegraph
CAPR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Capricor Therapeutics, Inc.(CAPR) Shareholders - Morningstar
Published on: 2025-08-14 06:24:14 - Newser
Capricor Therapeutics, Inc. Securities Fraud Class Action - GlobeNewswire
CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit - PR Newswire
Capricor Therapeutics shares rise 1.45% after-hours following a class action lawsuit announcement. - AInvest
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Capricor - GlobeNewswire
CAPRICOR THERAPEUTICS, INC. (NASDAQ: CAPR) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Capricor Therapeutics, Inc. Investors of Upcoming Deadline - ACCESS Newswire
CAPR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces That Capricor Therapeutics, Inc. Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Capricor Therapeutics, Inc. – CAPR - FinancialContent
What does recent volatility data suggest for Capricor Therapeutics Inc.Weekly Gains Report & Free Community Consensus Stock Picks - Newser
Lawsuit Alert: Investors who lost money with shares of Capricor - openPR.com
Investors in Capricor Therapeutics, Inc. Should Contact The Gross Law Firm Before September 15, 2025 to Discuss Your RightsCAPR - cnhinews.com
CAPR Stock News: Investors with Large Losses Should Contact Robbins LLP to Learn About Leading the Capricor Therapeutics, Inc. Class Action Lawsuit - Morningstar
Capricor Therapeutics Inc (CAPR) Q2 2025 Earnings Report Preview: What To Expect - Yahoo Finance
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP - GlobeNewswire
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Capricor Therapeutics - FinancialContent
Capricor: Q2 Earnings Snapshot - Norwalk Hour
Levi & Korsinsky Reminds Capricor Therapeutics, Inc. - GlobeNewswire
Capricor Therapeutics Inc (CAPR) Q2 2025 Earnings Call Highlights: Navigating Challenges with ... - Yahoo Finance
Capricor Therapeutics: Q2 2025 Financial and Strategic Update - TipRanks
Capricor Therapeutics Q2 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: Capricor Therapeutics Q2 2025 sees widened loss, stock dips - Investing.com Australia
Capricor Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire
A mild market reaction for companies on Prasad’s return - BioWorld MedTech
Vinay Prasad’s Return to FDA Sends Biotech Shares Tumbling - Bloomberg.com
0.41%
0.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):